Recombinant Human LPS Protein，His

LPS (lipopolysaccharide) recombinant proteins have garnered significant attention in the field of immunology and biotechnology due to their crucial role in the activation of the immune system. LPS are large molecules found in the outer membrane of gram-negative bacteria, and they play a pivotal role in triggering innate immune responses. The study of LPS has been instrumental in understanding how the immune system recognizes pathogens, leading to the activation of various immune cells and the production of pro-inflammatory cytokines. However, natural LPS is often toxic and difficult to handle, presenting challenges for research and therapeutic applications. Recombinant proteins derived from LPS provide a promising alternative, allowing for safer and more controlled studies. By engineering these proteins through recombinant DNA technology, researchers can produce LPS components in a laboratory setting, enabling in-depth investigations into their immunological effects and potential applications in vaccine development and immune modulation. Furthermore, the use of LPS recombinant proteins can aid in the development of diagnostic tools and the study of bacterial pathogenesis, ultimately contributing to better understanding and treatment of infectious diseases. This area of research continues to evolve, with advances in biotechnology paving the way for novel applications in medicine and immunotherapy.